Quantcast

Latest diarrhea Stories

2014-06-30 08:29:30

-- Company Expects to Initiate C. difficile Clinical Trials in 2014 -- ROCKVILLE, Md., June 30, 2014 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, announced today the formation of a Clinical Advisory Board (CAB) to support development of SYN-004, the Company's lead anti-infective product candidate for the prevention of the devastating...

2014-06-27 23:03:36

Moderate to severe diarrhea is a major cause of childhood mortality in developing countries and ranks as one of the top four causes of death among young children in sub-Saharan Africa and South Asia. In a finding that may one day help control this disease, researchers have identified microorganisms not widely linked to the condition previously that may trigger diarrheal disease and others that may protect against it. College Park, MD (PRWEB) June 27, 2014 In a finding that may one day...

2014-06-17 23:05:32

Rezvera.com now offers effective natural remedies for problems Like IBS, stomach bloating and diarrhea. Rezvera is a dietary supplement made of completely natural elements to aid the digestion process and eliminate any and all obstacles in the digestion process through active enzyme production. (PRWEB) June 17, 2014 Rezvera is a dietary supplement made of completely natural elements to aid the digestion process and eliminate any and all obstacles in the digestion process through active...

2014-06-16 20:22:11

AWARD-2: Once-Weekly Dulaglutide 0.75 mg Non-Inferior, 1.5 mg Superior in HbA1c Reduction from Baseline with Sustained Weight Loss and Lower Risk for Hypoglycemia SAN FRANCISCO, June 16, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today released detailed results from two AWARD trials that showed treatment with once-weekly dulaglutide 1.5 mg resulted in superior reductions in HbA1c from baseline compared to insulin glargine, with a lower risk for hypoglycemia.(1,2) Dulaglutide is an...

2014-06-10 12:31:05

LONDON, June 10, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Infectitious Diarrhea - Pipeline Review, H1 2014http://www.reportbuyer.com/pharma_healthcare/treatments/infectitious_diarrhea_pipeline_review_h1_2013.html Infectitious Diarrhea - Pipeline Review, H1 2014SummaryGlobal Markets Direct's, 'Infectitious Diarrhea - Pipeline Review, H1 2014', provides an overview of the Infectitious Diarrhea's therapeutic pipeline.This report provides comprehensive...

2014-06-10 04:22:10

-- Study to Define Impact of Beta-Lactam Antibiotics on Intestinal Bacteria -- ROCKVILLE, Md. and PARIS, June 10, 2014 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, and Enterome Bioscience SA, a pioneer in the development of innovative disease management solutions based on a deep understanding of the gut microbiome, today announced...

2014-06-09 08:28:32

GLASGOW, Scotland, June 9, 2014 /PRNewswire/ -- Grant to help fund Phase I trial with lead candidate oral MGB-BP-3 for Clostridium difficile MGB Biopharma, a biopharmaceutical company developing truly novel anti-infectives, announces today that it has been awarded a GBP1.3 million conditional grant from the Technology Strategy Board, the UK's innovation agency, under its Biomedical Catalyst programme. The grant will...

2014-06-02 16:26:19

- Ceritinib achieved overall response rate of 58.5%, with a median progression-free survival of 8.2 months1 EAST HANOVER, N.J., June 2, 2014 /PRNewswire/ -- Novartis today announced data showing Zykadia((TM) )(ceritinib, previously known as LDK378) shrank tumors in patients with anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer (NSCLC), including those who had received previous treatment with an ALK inhibitor as well as patients receiving one for the first time. Results...

2014-05-19 08:28:22

Results indicate vaccine generates an immune response against key toxins in volunteers and establish dosing for Phase III BOSTON, May 19, 2014 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), presented Phase II trial (H-030-012) results for an investigational vaccine for the prevention of Clostridium difficile (C. diff) infection (CDI) at the 114th General Meeting of the American Society for Microbiology (ASM). The Phase II trial met its...

2014-05-15 18:37:28

Wiley Zinc supplements reduce diarrhoea and other infections in malnourished children, and may prevent death, according to a new study published in The Cochrane Library. The study is the first Cochrane systematic review to focus on zinc as a means to prevent childhood death, including deaths caused by diarrhoea, one of the biggest killers of under-fives. Zinc is a micronutrient with important roles in growth and in the immune, nervous and reproductive systems. The human body cannot make...


Latest diarrhea Reference Libraries

0_9f897835bb09adc2a84fda23893d87f8
2011-04-15 13:50:01

Clostridium difficile, also known as "CDF/cdf", or "C. diff", is a Gram-positive bacteria of the genus Clostridium that causes severe diarrhea and other intestinal disease when competing bacteria in the gut flora are wiped out by antibiotics. They are anaerobic, spore-forming rods and is the most serious cause of antibiotic-associated diarrhea and potentially to pseudomembranous colitis. C. difficile bacteria naturally resides in the gut of a small percentage of the adult population. Others...

11_f79bc6a70a3ca6d0849bbfc3e310d871
2011-02-23 20:42:46

Rotavirus is the most common cause of diarrhea among infants and young children and is one of several viruses that cause the stomach flu. It is in the family Reoviridae and is a genus of double-stranded RNA. Most children have been infected by the age of five. Each infection builds on previous immunity and thus subsequent infections are less severe and adults are rarely affected. The fives species of the virus are referred to as A, B, C, D, and E. Type A, which is the most common, causes more...

45_7b9aa20b6263a73b7fcd4e869f868330
2011-02-17 17:29:15

Norovirus is an RNA virus that causes approximately 90% of epidemic non-bacterial outbreaks of gastroenteritis around the world. It may also be responsible for 50% of all foodborne outbreaks of gastroenteritis in the U.S. It can affect people of all ages and is transmitted by food or water that is contaminated, by person-to-person contact, and through aerosolization of the virus and subsequent contamination of surfaces. Immunity is usually incomplete and temporary after infection. People...

More Articles (3 articles) »
Word of the Day
barghest
  • A goblin in English folklore, often appearing in the shape of a large dog and believed to portend imminent death or misfortune.
  • A ghost, wraith, hobgoblin, elf, or spirit.
The origin of 'barghest' is not known, but it may be from perhaps burh-ghest, town-ghost, or German Berg-geist (mountain spirit) or Bär-geist (bear-spirit).
Related